News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Paolo Tarantino: Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer
Paolo Tarantino/X
Apr 12, 2025, 12:45

Paolo Tarantino: Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, posted on X:

“Results from OptiTROP-B01 out in Nature Medicine.

The TROP2-ADC sacituzumab tirumotecan improved PFS and OS in highly pretreated mTNBC, irrespective of Trop2 exp. Results similar to ASCENT. Approved in China, may soon also reach the west (4th topo1 ADC).”

“Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial.”

Authors: Yongmei Yin, Ying Fan, Quchang Ouyang, Lihua Song, Xiaojia Wang, Wei Li, Man Li, Xi Yan, Shusen Wang, Tao Sun, Yuee Teng, Xianjun Tang, Zhongsheng Tong, Zhengkui Sun, Junyou Ge, Xiaoping Jin, Yina Diao, Gesha Liu, Binghe Xu

Paolo Tarantino: Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer

Binghe Xu cancer Gesha Liu Junyou Ge Lihua Song Man Li Nature Medicine OncoDaily Oncology Paolo Tarantino Quchang Ouyang Shusen Wang Tao Sun triple-negative breast cancer Wei Li Xi Yan Xianjun Tang Xiaojia Wang Xiaoping Jin Yina Diao Ying Fan Yongmei Yin Yuee Teng Zhengkui Sun Zhongsheng Tong
Special Coverage
Blog
May 7, 2025, 19:03
Ane Appelt Highlights Max Tanaka’s RAPIDO Study on Dose Metrics and Bowel Toxicity in Rectal Radiotherapy
Blog
May 7, 2025, 18:51
David Gyorki Applauds Hayden Snow’s Work on Isolated Limb Perfusion for Sarcoma at Peter MacCallum
Blog
May 7, 2025, 18:24
From Policy to Action: Are We Ready to Bridge the Gap? - SPCC
Blog
May 7, 2025, 18:04
Carmen Saiz Guisasola: It Was Honour to Witness the Presentation of the EMBRACE-II Results This Morning at ESTRO 2025
Blog
May 7, 2025, 17:43
Hesham ElGhazaly Highlights Egypt-Algeria Collaboration in Cancer Control at Regional Summit
Blog
May 7, 2025, 17:20
Navigating Gavi: Supporting CSOs in Advancing Access to HPV Vaccination - UICC
Blog
May 7, 2025, 16:59
Happy National Nurses Week to Our Expert Infusion Nurses - Dana-Farber’s Breast Oncology Center
Blog
May 7, 2025, 16:37
ECO - Are you ready to support your young colleagues across Europe? 
Science
May 7, 2025, 16:29
Elie Dib: Talazoparib Confirmed Promising Activity in Solid Tumors With ATM Alterations
Science
May 7, 2025, 16:17
Mark Lewis: Fascinating discussion of bezoars at tumor board
Blog
May 7, 2025, 16:06
Isabel Mestres: I’m deeply honoured to have been elected to the 2025–2027 NCD Alliance Board of Directors
Blog
May 7, 2025, 15:53
Giuseppe Curigliano and Barbara Jereczek-Fossa have been elected to lead ESMO and ESTRO - IEO European Institute of Oncology